Iron

The most abundant transition metal in the human body and arguably the most consequential metal in biology. Iron sits at the center of a paradox that drives pathology across virtually every disease domain: organisms need it for oxygen transport, energy metabolism, DNA synthesis, and immune defense, yet its redox activity makes it dangerous when uncontrolled. This tension between necessity and toxicity shapes the ecology of the gut microbiome, the outcome of infections, and the trajectory of neurodegeneration, cancer, and cardiovascular disease.

What sets iron apart from every other metal in this wiki is its role as the primary currency of the war between hosts and pathogens. The host sequesters iron to starve invaders. Pathogens evolve siderophores, hemolysins, and heme receptors to steal it back. The microbiome's composition at any given moment is, in large part, a reflection of who is winning the iron war.

Overview

Evolutionary Origins

Iron's centrality to biology is not accidental — it reflects the chemistry of the planet where life originated. Analysis of 3.33-billion-year-old carbonaceous material from the Barberton greenstone belt reveals that iron was among the key bio-functional elements in Earth's earliest ecosystems, enriched in biogenic material alongside vanadium, nickel, and cobalt ^[1]. The pre-Great Oxygenation Event world was an iron-rich, anoxic environment where life evolved to depend on iron's redox versatility. Metals that became biologically important only after oxygenation — zinc and molybdenum — are absent or below detection in these ancient specimens ^[1]. The modern biological dependency on iron is therefore a 3.3-billion-year inheritance from the geochemistry of early Earth.

Chemical Properties

• Transition metal cycling between Fe2+ (ferrous) and Fe3+ (ferric) states — this redox cycling is both its biological utility and its danger.
• Fenton reaction: Fe2+ + H2O2 -> Fe3+ + OH- + OH* generates hydroxyl radicals, the most reactive oxygen species ^[2]. Iron, copper, vanadium, chromium, and cobalt all participate in Fenton-type chemistry, but iron is the most biologically abundant ^[3].
• Iron is one of the two most abundant intracellular transition metals (alongside zinc), reaching tens of millimolar total concentration in typical cells ^[4].
• Fe enzymes come in three structural forms: nonheme iron, iron-sulfur (Fe-S) cluster-containing, and heme enzymes — each with distinct vulnerability profiles ^[4].
• In the Irving-Williams series (Mg < Mn < Fe < Co < Ni < Cu > Zn), iron occupies the middle ground — strong enough to be a versatile catalytic cofactor, but weak enough to be displaced by copper or zinc when homeostasis fails ^[5].

Homeostatic Regulation

• Regulated by the hepcidin-ferroportin axis: hepcidin controls iron absorption from dietary sources, macrophages, and body stores ^[6].
• Key transport proteins: DMT1 (SLC11A2) for import, ferroportin (SLC40A1) for export, transferrin for plasma transport, ferritin for storage ^[6].
• Iron regulatory proteins (IRP1/2) sense cellular iron and post-transcriptionally regulate transferrin receptor and ferritin expression ^[6].
• Nickel can oxidize iron in iron-sulfur clusters and iron-containing hydroxylases, disrupting IRP-1/IRP-2, transferrin receptor, and ferritin levels ^[7].

Biological Roles

Iron as the Ancestral Enzyme Cofactor

A landmark finding from the Imlay lab demonstrates that iron was the ancestral metal cofactor for mononuclear enzymes, later replaced by manganese or zinc in organisms that colonized oxidizing environments. The enzyme ribulose-5-phosphate 3-epimerase (Rpe) illustrates this: E. coli and Bacteroides metalate Rpe with iron, while B. subtilis and Lactococcus use manganese, and S. cerevisiae uses zinc — yet the metal-coordinating residues are identical across all organisms ^[8]. The metal pool, not the protein, determines which cofactor is incorporated. Iron-charged Rpe has the highest catalytic turnover but is instantly inactivated by 0.1 mM hydrogen peroxide via Fenton chemistry at the active site; manganese-charged Rpe is fully resistant ^[8]. This reveals a fundamental evolutionary trade-off: organisms sacrifice catalytic efficiency for oxidative stress resistance when they switch from iron to manganese cofactors.

E. coli can conditionally switch Rpe from iron to manganese under peroxide stress, mediated by OxyR-induced MntH manganese import and Dps miniferritin sequestration of free iron ^[8]. This conditional metal switching is a key survival strategy that connects iron biology to the oxidative stress response.

Metalloproteome Architecture

Approximately 25% of all metalloenzymes use iron as a cofactor, and 33-40% of a typical proteome consists of metalloproteins ^[4], ^[9]. Iron's three enzyme families serve distinct functions:

• Nonheme iron enzymes: Include ribonucleotide reductase (essential for DNA synthesis) and lipoxygenases (lipid signaling)
• Iron-sulfur cluster enzymes: Aconitase, respiratory complexes I-III, nitrogenase — these are exquisitely vulnerable to disruption by copper, nickel, and oxidative stress
• Heme enzymes: Cytochromes, catalase, peroxidases, hemoglobin, myoglobin

Iron is in high demand for Fe-S clusters and heme cofactors that manganese cannot substitute for, making these enzyme families irreplaceable even when organisms switch other enzymes to manganese ^[9].

Iron-Sulfur Clusters as the Critical Vulnerability

Iron-sulfur clusters are the single most important target connecting iron biology to disease, toxicity, and immune defense. Fe-S clusters are solvent-accessible in many enzymes and thermodynamically vulnerable to displacement by stronger-binding metals:

• Copper destroys Fe-S clusters in isopropylmalate isomerase (IPMI), fumarase A, and glutamate synthase (GOGAT), causing branched-chain amino acid auxotrophy and glutamate starvation ^[10].
• Nickel and copper together produce synergistic Fe-S cluster damage at environmentally relevant concentrations where neither metal alone causes toxicity. Combined Ni/Cu exposure in E. coli triggers upregulation of ISC Fe-S cluster assembly genes and produces 70% of differentially expressed genes unique to the combination ^[11].
• Reactive nitrogen species from macrophage iNOS also damage Fe-S clusters, adding a third axis of vulnerability alongside copper and nickel ^[12].

The vulnerability of Fe-S clusters means that iron biology cannot be understood in isolation — it is the target where copper toxicity, nickel toxicity, and oxidative/nitrosative stress all converge.

Role in Wound Healing

In a murine wound healing time course, iron shows a distinctive temporal profile: elevated at days 7-14 during the proliferation and remodeling phases, linked to oxidoreductase activity, heme-binding, steroid hydroxylase, and PPAR signaling pathways ^[13]. Metal-linked genes constitute 16% of wound-responsive genes with nearly 2-fold overrepresentation, establishing metals as active orchestrators of tissue repair rather than passive bystanders ^[13]. Iron-binding gene keywords in the wound transcriptome cluster with oxidoreductase, heme binding, aromatase, and metabolic processes ^[13].

Dietary and Environmental Sources

Dietary

• Heme iron (meat, fish) is more bioavailable than non-heme iron (plants, fortified foods).
• Iron-fortified infant cereals and formulas are significant sources for infants.
• Iron detected in 100% of tampon samples at measurable concentrations ^[14].

Iron and the Dose-Response Paradox

Essential elements follow a characteristic dose-response curve: deficiency causes harm at low concentrations, optimal performance at moderate levels, and toxicity at high concentrations ^[3]. For iron this curve is unusually narrow — the margin between deficiency (anemia, impaired immunity) and excess (oxidative damage, pathogen feeding) is clinically treacherous, which is why iron status is the most frequently disrupted metal parameter across disease states.

Prenatal and Infant Exposure

Maternal trace element profiles shape the infant gut microbiome. In a prospective cohort of 146 mother-infant pairs, prenatal metal exposure patterns measurably affected gut microbial diversity and composition at 3, 6, and 12 months of life ^[15]. Iron supplementation in infants increases Enterobacteriaceae and decreases Lactobacillus; in African children, iron supplementation increased Bacteroidetes ^[6]. The developmental window of iron-microbiome interaction is a critical period whose long-term consequences remain poorly understood.

Environmental and Occupational

• Iron is a co-exposure in welding fumes alongside manganese and nickel ^[16].
• Urinary iron levels showed statistically significant differences across infant feeding groups in an aerodigestive clinic cohort, though levels did not exceed toxicity thresholds ^[17].

Microbiome Interactions

Iron Shapes the Commensal-Pathogen Balance

Iron availability in the gut lumen is one of the primary determinants of microbial community structure. Iron deficiency reduces commensal beneficial bacteria (Lactobacillus, Bacillota) while iron excess increases harmful bacteria (Bacteroides, E. coli, Enterobacteriaceae) ^[6]. Iron deficiency anemia (IDA) specifically reduced Bacillota abundance while increasing Bacteroidota, Pseudomonadota, and Patescibacteria ^[6].

The mechanism is competitive: siderophore-producing Enterobacteriaceae outcompete commensals under high-iron conditions because commensals generally lack the aggressive iron acquisition systems that pathogens deploy ^[18]. Iron, manganese, and nickel availability in the gut lumen determines competitive outcomes between commensals and pathogens ^[18].

Strategic Metal Cofactor Selection

Different gut organisms have adopted fundamentally different iron strategies. Anaerobes and facultative anaerobes (E. coli, Bacteroides thetaiotaomicron) use iron as the default enzyme cofactor, exploiting its superior catalytic properties in the low-oxygen gut environment ^[8]. Aerotolerant organisms like Lactobacillus and Lactococcus constitutively use manganese instead, sacrificing catalytic efficiency for protection against the oxidative damage that iron cofactors invite ^[8]. This metal strategy difference is one reason why iron supplementation selectively favors iron-dependent pathobionts over manganese-dependent commensals.

Metalloproteome Plasticity During Infection

Under immune-imposed metal restriction, bacteria can deliberately switch the metal cofactors in their enzymes. Salmonella in macrophages increases Mn2+ uptake via MntH and SitABC transporters while simultaneously reducing Fe2+ use — a purposeful metalloproteome remodeling that trades catalytic efficiency for oxidative stress resistance ^[9]. Cambialistic enzymes like S. aureus SodM can function with either iron or manganese, giving pathogens metabolic flexibility that strict iron-dependent organisms lack ^[9].

The Microbiome as Intermediary in Neurodegeneration

A unifying framework proposes that metal dyshomeostasis initiates vulnerability, and the microbiome amplifies and operationalizes it. Altered host iron handling increases labile metal pools, creating selection pressure for microbes capable of surviving and exploiting metal-rich, inflammatory environments along the gut-brain axis ^[19]. Dysbiosis in this model reflects functional enrichment for metal resistance and virulence — not a nonspecific imbalance ^[19]. Gut microbiota influence the host via metabolites: SCFAs (butyrate enhances epithelial barrier), indole derivatives, bile acids, and neurotransmitters (serotonin, dopamine, GABA) ^[6].

Metal-Microbiome-Behavior Link

Heavy metal load, microbiome-associated metabolites, and catecholamine ratios together account for 32% of variance in social behaviors in children. The gut microbiome alters the metabolic outcomes of heavy metals, and heavy metals influence microbiome viability and metabolism — creating a bidirectional interaction where iron, zinc, and copper displacement by toxic metals disrupts microbial enzyme function ^[20].

Nutritional Immunity

Iron is the centerpiece of nutritional immunity — the host strategy of sequestering metals to starve invading pathogens. But nutritional immunity is not just about withholding iron. It is a coordinated two-front war: the host simultaneously starves pathogens of iron in the extracellular space and floods them with toxic copper and zinc inside phagosomes.

Host Iron Sequestration

• Transferrin and lactoferrin bind extracellular iron; hemopexin and haptoglobin scavenge heme from lysed red blood cells ^[21].
• Lactoferrin concentrations increase 6.6-fold with bacterial vaginosis and 11.5-fold with Trichomonas vaginalis infection; lactoferrin is positively associated with serum hepcidin and ferritin ^[22].
• Iron-deficient women had lower vaginal lactoferrin and were more susceptible to genital infections — a vicious cycle where iron deficiency weakens the very defense mechanism designed to restrict iron from pathogens ^[22].
• Hepcidin dysfunction is proposed as a primary trigger for iron dysregulation in Parkinson's disease; SARS-CoV-2 proteins interact with the TMPRSS6/hepcidin pathway, suggesting viral infection could trigger neurodegeneration via iron dysregulation ^[23].

Metal Weaponization: The Other Side of Immunity

While iron is withheld, the immune system simultaneously floods pathogens with toxic zinc and copper. Host peptidoglycan recognition proteins (PGRPs) induce 60-100x increases in intracellular Zn2+ and Cu+ in target bacteria ^[24]. This metal weaponization is not optional — chelation of either zinc or copper completely abolished PGRP bactericidal activity, demonstrating that metal intoxication is a required component of immune killing ^[24].

The iron connection is direct: copper toxicity kills bacteria primarily by destroying iron-sulfur clusters in metabolic enzymes ^[10], and zinc toxicity kills by displacing manganese from enzymes that bacteria switched to precisely to avoid iron-related oxidative damage ^[25]. Every axis of metal-mediated immune killing ultimately converges on disrupting the iron-dependent or iron-replacement enzyme systems.

Pathogen Iron Acquisition

Pathogens have evolved elaborate systems to overcome host iron restriction:

• Staphylococcus aureus: Produces staphyloferrin A and B siderophores; uses the Isd heme acquisition system; hemolysins lyse red blood cells to release hemoglobin. Heme is the preferred iron source during infection ^[21].
• Streptococcus pneumoniae: Requires iron for viability; uses hemoglobin and heme (NOT transferrin or lactoferrin) as sole iron sources via 22 and 37 kDa membrane proteins ^[26]. The pneumococcal cell wall itself serves as a metal reservoir — peptidoglycan and teichoic acids bind divalent cations that buffer against host-imposed metal restriction ^[27].
• Group B Streptococcus: A Mn-centric organism that relies on manganese for SOD activity; host Mn restriction via calprotectin is therefore a potent anti-GBS strategy. GBS has evolved copper efflux (CopA) and zinc efflux systems specifically to counter phagosomal metal flooding ^[12].
• Siderophores are the most diagnostically important metallophores; detection via mass spectrometry can identify pathogens faster than culture ^[28].

The Siderophore Ecology

Siderophores are small molecules evolved by bacteria to scavenge iron from the host environment. They represent the pathogen's answer to nutritional immunity, and their diversity reveals the intensity of the evolutionary arms race for iron.

Siderophore-antibiotic conjugates (Trojan horses) exploit the pathogen's own iron hunger against it. By attaching antibiotics to siderophore structures, drugs are actively imported through the pathogen's iron uptake machinery. This achieves MICs 100-fold lower than passive diffusion because active transport concentrates the drug precisely where it acts ^[29]. Salmochelin-beta-lactam conjugates achieve 100-1000x enhanced activity against uropathogenic E. coli while sparing commensal Lactobacillus, because the IroN salmochelin receptor is encoded on a virulence-associated genomic island absent from commensals — the first demonstration of pathogen-selective antibiotic action ^[30].

Competitive iron deprivation takes a different approach: natural pyoverdine siderophores from Pseudomonas species can outcompete target pathogens' own siderophores for iron. A systematic screen of 320 pyoverdine variants identified specific structural variants that potently inhibit Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus ^[31]. Resistance evolution against pyoverdines is slower than against conventional antibiotics, because the target — iron acquisition — is a fundamental metabolic requirement rather than a single enzyme ^[31].

Gallium as an iron mimic represents perhaps the most elegant exploitation of iron dependency. Ga3+ has nearly identical ionic radius and coordination geometry to Fe3+, and bacteria cannot distinguish between them. But gallium is redox-inactive — once incorporated into iron-dependent enzymes like ribonucleotide reductase, it permanently inactivates them, halting DNA synthesis ^[32]. Galbofloxacin, a rationally designed Ga3+-siderophore-fluoroquinolone conjugate, achieves an MIC of 93 nM against S. aureus — roughly 1000-fold more potent than unconjugated fluoroquinolones ^[33]. Resistance to gallium is intrinsically difficult because blocking gallium entry would simultaneously block essential iron uptake ^[32].

Assisted Nutritional Immunity

The concept of "assisted nutritional immunity" uses pharmacological iron chelation not to kill bacteria directly but to amplify the host's own metal-withholding defense. Deferiprone reduced intracellular iron by 33.1% and bacterial load by 78% in macrophages infected with Piscirickettsia salmonis, with in vivo fish mortality reduced by 34.9% ^[34]. The disproportionate effect — modest iron reduction causing dramatic bacterial reduction — suggests pathogens operate near the threshold of iron sufficiency, making them exquisitely sensitive to restriction ^[34].

Multi-metal chelation strategies may be more effective than single-metal approaches, as pathogens can compensate for one metal restriction by upregulating alternative pathways ^[35]. Disrupting metal homeostasis disarms virulence without directly killing bacteria — a fundamentally different mechanism from conventional antibiotics that reduces resistance selection pressure ^[35].

Siderophores Beyond Infection

Siderophores have therapeutic applications beyond antimicrobials. Desferrioxamine (DFO, originally a bacterial siderophore from Streptomyces pilosus) inhibits P. falciparum growth by depriving the malaria parasite of iron required for intraerythrocytic development ^[36]. Enterobactin causes iron-depletion-driven cancer cell apoptosis, and siderophore-hapten conjugates function as vaccines against uropathogenic E. coli by exploiting obligate siderophore receptor expression to target immune responses specifically to pathogens ^[36]. Siderophores loaded with radiometals (68Ga, 89Zr) enable PET imaging of bacterial infections by tracking where bacteria are actively scavenging iron ^[36].

Conditions Associated

Ferroptosis: The Cross-Condition Cell Death Mechanism

Ferroptosis — iron-dependent programmed cell death via lipid peroxidation — emerges as a convergent pathological mechanism linking iron to disease across multiple organ systems.

• Iron catalyzes Fenton reactions generating hydroxyl radicals that drive lipid peroxidation; GPX4 (glutathione peroxidase 4) downregulation removes the brake on ferroptotic cell death ^[18].
• Ferroptosis serves as the convergent cell death mechanism in both gut epithelial damage and dopaminergic neuron loss in Parkinson's disease ^[18].
• Iron-dependent phospholipid peroxidation in renal tubular cells; iron-restricted diet protective in CKD animal models ^[37].
• GPX4 identified as ferroptosis regulator in thyroid cancer ^[38].
• In the tumor microenvironment, iron overload promotes M2 macrophage polarization (immunosuppressive), while iron-loading interventions can sensitize ferroptosis-resistant tumors ^[39].

Neurodegeneration

• Parkinson's disease: Iron accumulation in the substantia nigra is a PD hallmark. Iron is the "concert master" — it orchestrates multiple pathogenic pathways simultaneously. Transferrin is decreased by 35% in the PD substantia nigra while lactoferrin is increased; blood-brain barrier dysfunction permits unregulated iron uptake ^[23]. Iron binding to alpha-synuclein promotes aggregation and Lewy body formation; dramatic loss of glutathione in glia suggests that iron accumulation and GSH loss may be pre-symptomatic markers ^[23]. The pathology likely spreads in a prion-like manner from the gut via the vagus nerve, fitting the bottom-up (gut-brain) hypothesis where metal dyshomeostasis starts in the gut and propagates centrally ^[23].
• Pheomelanin-neuromelanin hypothesis: In redheads (MC1R variants), higher pheomelanin-to-eumelanin ratio in neuromelanin reduces iron sequestration capacity, increasing free iron and ferroptotic vulnerability ^[40].
• Alzheimer's disease: Iron accumulation in hippocampus and cortex; iron participates in Fenton reactions generating hydroxyl radicals and promotes amyloid-beta aggregation and tau phosphorylation ^[2], ^[41].
• Dementia with Lewy bodies: Fe and alpha-synuclein interactions create a vicious cycle; widespread copper decreases and localized iron/selenium changes distinguish DLB, AD, and PDD metallomic profiles ^[42].

Postpartum Depression

• Postpartum anemia significantly increases PPD risk: RR = 1.887 (95% CI: 1.255-2.838) across 10 studies ^[43].
• Iron deficiency alters concentrations of cytochrome C, dopamine, serotonin, and GABA, with adverse effects on brain function ^[44].
• Iron is essential for dopamine synthesis; elevated copper alongside iron deficiency in PPD suggests a Cu/Fe imbalance in pathophysiology ^[45].

Thyroid Disease

• Iron deficiency decreases TPO activity, leading to reduced T3/T4 synthesis and increased TSH ^[38].
• 58% of Hashimoto's thyroiditis patients have iron deficiency anemia ^[38].
• Iron has immunomodulating effects on M1/M2 macrophage polarization ^[46].

Cardiovascular Disease

• Iron decreased in AMI patients (0.95 vs 1.17 ug/mL); Fe/Cu ratio significantly decreased and is a more sensitive AMI biomarker than individual element concentrations ^[47].
• Cu/Se and Fe/Cu ratios incorporated into a random forest model achieved AUC of 0.942 for AMI classification ^[47].

Cancer

• Iron elevated in prostate cancer (1.96 vs 1.24 ug/ml, p<0.05); increased Fe may promote oxidative stress via Fenton reaction ^[48].
• In the tumor microenvironment, iron is both hoarded by tumor cells for proliferation and used to polarize tumor-associated macrophages toward the immunosuppressive M2 phenotype ^[39].
• Metal-induced dysbiosis reduces SCFA-producing bacteria, and SCFAs may influence iron-dependent cell death through epigenetic regulation of ferroptosis-related genes ^[49].

Diabetes

• Elevated ferritin correlates with insulin resistance at preclinical stages of T2D; hemochromatosis increases hepatocarcinoma risk ^[50].
• Fe oxidizes biomolecules, decreasing insulin secretion ^[50].

Major Depressive Disorder

Shotgun metagenomic analysis of MDD patients reveals pathway-level disruptions connecting iron metabolism to depression. MDD-enriched pathways include LPS biosynthesis, serotonin degradation, and folate transformations, while protective taxa depleted in MDD (Faecalibacterium prausnitzii, Coprococcus) are SCFA producers whose loss compromises gut barrier integrity and anti-inflammatory signaling ^[51]. The NIMETOX framework positions iron redistribution (not necessarily deficiency) as part of the neuro-immune-metabolic cascade in depression ^[51].

Mis-metallation by Other Metals

Iron-containing enzymes are targets for disruption by toxic metals:

• Cadmium displaces iron (and zinc and manganese) from metalloproteins. In S. pneumoniae, Cd mis-metalates at least 16 metalloproteins including glycolytic enzymes and superoxide dismutase, forcing metabolic rerouting from glycolysis to the pentose phosphate pathway ^[52]. Cadmium accumulation is higher in iron-depleted women, potentially impairing lactoferrin-mediated antimicrobial defense ^[22].
• Nickel disrupts iron homeostasis: Ni(II) substitutes for Fe(II) in enzyme active sites, oxidizes iron in iron-sulfur clusters, and affects IRP-1/IRP-2 regulation ^[7].
• MnSOD in E. coli is frequently mis-metalated with iron under iron-replete conditions, rendering the enzyme inactive — demonstrating that mis-metallation is not hypothetical but a routine cellular challenge ^[5].

Key Studies

Source	Year	Evidence Level	Key Finding
[1]	2020	Expert opinion	Iron as bio-essential element from 3.33 Ga; evolutionary origin of iron dependency
[8]	2024	In-vitro	Strategic metal cofactor selection — iron as ancestral cofactor with highest catalytic turnover
[4]	2024	Expert opinion	Metallostasis framework; 33-40% of proteome is metalloprotein; Irving-Williams inverse availability
[23]	2021	Expert opinion	Iron as "concert master" in PD; transferrin decreased 35% in SN; gut-brain-axis propagation
[24]	2014	In-vitro	PGRP immune killing requires metal intoxication; chelation abolishes bactericidal activity
[10]	2024	Animal model	Cu toxicity operates through Fe-S cluster destruction; BCAA auxotrophy
[31]	2024	In-vitro	320 pyoverdines screened; competitive iron deprivation with reduced resistance evolution
[33]	2021	Animal model	Gallium Trojan horse; 93 nM MIC against S. aureus via ferrichrome transport
[30]	2015	In-vitro	First pathogen-selective siderophore antibiotic; spares commensal Lactobacillus
[34]	2020	Animal model	"Assisted nutritional immunity" — 33% iron reduction causes 78% bacterial reduction

Biomarkers

• Serum ferritin: Reflects iron stores; postpartum anemia associated with 1.89x PPD risk ^[43]; elevated in T2D and cancer ^[50].
• Hepcidin: Master regulator of iron homeostasis; hepcidin elevation during infection indicates functional iron restriction (host defense), not necessarily true deficiency — a critical interpretive distinction ^[23], ^[22].
• Fe/Cu ratio: Decreased in AMI; more sensitive than individual elements; AUC 0.942 in a 10-feature model combining metallomic ratios with traditional risk factors ^[47].
• Transferrin receptor (sTfR): Reflects tissue iron demand; transferrin decreased 35% in PD substantia nigra ^[23].
• Siderophore detection: Iron-acquiring metallophores as biomarkers for invasive bacterial and fungal infections; siderophores loaded with radiometals enable PET imaging of infection sites ^[28], ^[36].
• Calprotectin: Sequesters manganese and zinc at infection sites; elevated calprotectin reflects active nutritional immunity and is a standard IBD biomarker ^[12].

Interactions with Other Metals

Metal	Interaction with Iron	Key Source
Copper	Cu+ destroys Fe-S clusters; Cu/Fe ratio is cardiovascular biomarker; Cu elevation with Fe decrease in AMI	[10], [47]
Nickel	Ni2+ oxidizes Fe in Fe-S clusters; substitutes for Fe2+ in enzyme active sites; synergistic Fe-S damage with Cu	[7], [11]
Manganese	Fe and Mn interchangeable in mononuclear enzymes; organisms switch Fe→Mn under oxidative stress; competes for DMT1 transport	[8], [9]
Zinc	Zn displaces Fe from some binding sites; Zn flooding kills bacteria by targeting Mn-dependent enzymes that replaced Fe-dependent ones	[25], [5]
Cadmium	Cd displaces Fe/Zn/Mn from metalloproteins; Cd accumulation increased in Fe-depleted individuals; 16+ mis-metallation targets in pneumococcus	[52], [22]
Gallium	Ga3+ mimics Fe3+ but is redox-inactive; poisons Fe-dependent enzymes irreversibly; exploitable as Trojan horse antimicrobial	[33], [32]
Selenium	Se and Fe cooperate in GPX4-mediated antioxidant defense; Se deficiency compounds ferroptotic vulnerability	[18]

Open Questions

• Whether ferroptosis-targeted therapies (iron chelation, GPX4 activation) can be effective across neurodegeneration, CKD, and cancer simultaneously, or whether tissue-specific iron regulation requires condition-specific approaches.
• How to optimize iron status to support immune function (lactoferrin, PGRP metal weaponization) without feeding siderophore-producing pathobionts — the central clinical dilemma of iron management.
• The role of neuromelanin iron-binding capacity in explaining differential PD risk by MC1R genotype (redhead hypothesis).
• Whether siderophore-based diagnostics (mass spectrometry, PET imaging) can replace or complement culture-based pathogen identification in clinical practice.
• How iron-microbiome interactions in infancy (through formula and supplementation) shape long-term health trajectories, given the evidence that prenatal metal exposure patterns persist in infant gut microbiome composition for at least 12 months.
• Whether the Fe/Cu ratio can be validated as a clinical cardiovascular biomarker beyond the AMI setting.
• Quantitative thresholds for mis-metallation in vivo — how much metal perturbation is required to exceed cellular buffering capacity and trigger cascading enzyme failure ^[5].
• Whether oral gallium nanoparticles can achieve therapeutically relevant concentrations in the gut lumen to selectively target iron-dependent pathobionts while sparing manganese-dependent commensals.
• The extent to which gut lumen iron ratios (rather than systemic iron status) determine commensal vs. pathogen competitive outcomes — a fundamentally different compartment than serum.

Cross-References

• ferroptosis — iron-dependent lipid peroxidation as convergent cell death mechanism
• nutritional immunity — host iron sequestration as primary antimicrobial defense
• siderophores — pathogen iron acquisition and Trojan horse antimicrobial strategies
• mis metallation — iron-sulfur clusters as the convergent target of metal toxicity
• parkinsons disease — iron accumulation in substantia nigra; ferroptotic dopaminergic neuron death
• alzheimers disease — iron accumulation in hippocampus and cortex; amyloid-beta aggregation
• postpartum depression — iron deficiency anemia increases PPD risk 1.89-fold
• gut microbiome — iron status shapes commensal vs pathogen balance
• gut brain axis — iron-microbiome-neurodegeneration link
• nickel — Ni disrupts Fe homeostasis via enzyme active site substitution and Fe-S cluster damage
• copper — Cu destroys Fe-S clusters; Fe/Cu ratio as cardiovascular biomarker
• manganese — Fe/Mn interchangeability in enzymes; competitive DMT1 transport
• zinc — Zn flooding targets Mn-dependent enzymes that replaced Fe-dependent ones
• cadmium — increased Cd absorption in iron-depleted individuals; proteome-wide mis-metallation
• gallium — redox-inactive Fe mimic; Trojan horse antimicrobial strategy
• selenium — cooperates with Fe in GPX4-mediated antioxidant defense
• staphylococcus aureus — elaborate siderophore and heme acquisition systems
• streptococcus pneumoniae — cell wall as metal reservoir; heme as sole iron source
• escherichia coli — siderophore competition; salmochelin as virulence marker
• lactoferrin — iron-binding glycoprotein central to mucosal immune defense
• glutathione — GSH required for GPX4 defense against ferroptosis; linchpin of triple-stress immune killing
• dyshomeostasis — iron dyshomeostasis as the prototype metal imbalance across disease domains
• metal chelation therapy — deferiprone, deferoxamine in neurodegeneration and iron overload